BiotechTube
Home/Kriya Therapeutics/Mari Beth Tandy
MB

Mari Beth Tandy

SVP, Quality Assurance

Kriya Therapeutics

Therapeutic Areas

OphthalmologyMetabolic DiseaseNeurology

Kriya Therapeutics Pipeline

DrugIndicationPhase
Ophthalmology ProgramGeographic AtrophyUnknown
Metabolic Disease ProgramType 1 DiabetesUnknown
Neurology ProgramTrigeminal NeuralgiaUnknown

Leadership Team at Kriya Therapeutics

GD
Greg Di Russo
Chief Medical Officer
SM
Sachiyo Minegishi
Chief Financial Officer
CO
Catherine Oldham-Creamer
SVP, Clinical Operations
View full Kriya Therapeutics profile